Revenio Group Oyj - Company Announcement

Revenio Group Corporation: Revenio Group Corporation's Capital markets Day on August 28, 2013

Revenio Group Corporation         Stock Exchange Release   August 28, 2013 at
10:00 a.m.

Revenio Group Corporation's Capital markets Day on August 28, 2013

Revenio Group Corporation is organizing a Capital Markets Day for analysts,
portfolio managers and media representatives on August the 28th, 2013 starting
at 11:30 a.m. in Helsinki.

The day's presentations will concentrate on Revenio's and especially on its
subsidiary Icare Finland Oy's updated strategy and growth drivers. The speakers
of the event are Olli-Pekka Salovaara, President and CEO of Revenio; Timo
Hilden, CEO of Icare Finland Oy; John Floyd, CEO of Icare USA and Pekka
Raatikainen, CFO of Revenio.

Revenio is a Finnish health tech group whose core business is Icare's
tonometers. Tonometers are used to identify and screen for Glaucoma, that is,
chronic elevated pressure within the eye. Revenio strives for growth in health
technology, both organically and inorganically. In addition to organic growth,
Revenio seeks opportunities to supplement its current product portfolio with
innovative health tech products with growth potential that would complement
Icare's existing global distribution network. The objective is to utilize
Icare's existing distribution network with a more comprehensive product
portfolio for wider customer base.

According to Revenio's view, the major growth drivers for Icare Finland Oy's
business operations are aging population and population growth, the global cost
pressure in the health care, the increasing awareness of Glaucoma and the growth
of patient driven eye pressure screenings.

Revenio Group Corporation's financial guidance remains unchanged.  In continuing
operations, consolidated net sales and operating profit excluding non-recurring
items are expected to see year-on-year growth.

The Capital Markets Day's presentation is available on Revenio's website
www.revenio.fi at 12:00 p.m. on August the 28(th), 2013, onwards.

Revenio Group Corporation

Olli-Pekka Salovaara
CEO and President

For additional information:
Pekka Raatikainen, CFO
Tel. +358 50 553 4094
E-mail: pekka.raatikainen@revenio.fi

DISTRIBUTION:
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi


The Revenio Group in brief
Revenio is a Finnish health tech group whose core business is tonometers. The
Revenio Health Tech segment comprises the business operations of Icare Finland
Oy. The widely patented Icare product family is the current cornerstone of the
Group's success. Revenio seeks vigorous growth in health technology, both
organically and through acquisitions and mergers.

The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products and
services in their industry. These businesses are extremely profitable in their
industries and generate positive cash flow.

In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its
operating margin standing at 19.4 percent. The Revenio Group Corporation is
listed on NASDAQ OMX Helsinki.


[HUG#1724781]